Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current State of “Omics” Biomarkers in Pancreatic Cancer
Beste Turanlı, Esra Yıldırım, Gizem Gülfidan, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 127-127
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Biomarkers, Omics and Artificial Intelligence for Early Detection of Pancreatic Cancer.
Kate Murray, Lucy Oldfield, Irena Stefanova, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 76-88
Closed Access | Times Cited: 1
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3406-3406
Open Access | Times Cited: 7
Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 10, pp. 1229-1243
Open Access | Times Cited: 27
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
Development of PDAC diagnosis and prognosis evaluation models based on machine learning
Yingqi Xiao, Shixin Sun, Nanshan Zheng, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer
Eleazer P. Resurreccion, Ka-wing Fong
Metabolites (2022) Vol. 12, Iss. 6, pp. 488-488
Open Access | Times Cited: 17
Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma
Sahar Akrami, Ahmad Tahmasebi, Ali Moghadam, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106529-106529
Open Access | Times Cited: 9
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
Alessandro Coppola, Vincenzo La Vaccara, Tommaso Farolfi, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2091-2091
Open Access | Times Cited: 15
Proteomics-Driven Biomarkers in Pancreatic Cancer
Luís Ramalhete, Emanuel Vigia, Rúben Araújo, et al.
Proteomes (2023) Vol. 11, Iss. 3, pp. 24-24
Open Access | Times Cited: 8
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Nathan R. Wall, Ryan N. Fuller, Ann Morcos, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5070-5070
Open Access | Times Cited: 7
Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis
Tanakamol Mahawan, Teifion Luckett, Ainhoa Mielgo Iza, et al.
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. S4
Open Access | Times Cited: 2
DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family
Shaohan Wu, Xiaofang Sun, Ruheng Hua, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer
Paul Manoukian, Leo C Kuhnen, Hanneke W.M. van Laarhoven, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 206, pp. 104573-104573
Open Access | Times Cited: 2
Metabolomics of Duodenal Juice for Biliary Tract Cancer Diagnosis
Kazuma Kishi, Masaki Kuwatani, Yuki Ohnishi, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4370-4370
Open Access | Times Cited: 6
GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses
Youfu Zhang, Jinran Yang, Xuyang Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies
Büşra Aydın, Aysegul Caliskan, Kazım Yalçın Arğa
The EPMA Journal (2021) Vol. 12, Iss. 3, pp. 383-401
Open Access | Times Cited: 11
Prediction of Pathologic Change Development in the Pancreas Associated with Diabetes Mellitus Assessed by NMR Metabolomics
Lenka Michálková, Štěpán Horník, Ján Sýkora, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 6, pp. 1936-1946
Open Access | Times Cited: 4
Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer
Wan‐Jou Shen, Hsuan-Min Kao, Chih‐Yang Wang, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 11, pp. 2158-2169
Open Access | Times Cited: 1
Electrochemical immunoplatform to help managing pancreatic cancer
Víctor Pérez‐Ginés, Rebeca M. Torrente‐Rodríguez, Marı́a Pedrero, et al.
Journal of Electroanalytical Chemistry (2023) Vol. 935, pp. 117312-117312
Open Access | Times Cited: 3
Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology
Leire Pedrosa, Isis K. Araujo, Míriam Cuatrecasas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer
Md. Roman Mogal, Asadullah Junayed, Md. Rashel Mahmod, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 5
Recent Developments in Cancer Systems Biology: Lessons Learned and Future Directions
Kazım Yalçın Arğa, Raghu Sinha
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 271-271
Open Access | Times Cited: 5
Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model
Tatiana J. Carneiro, Joana Pinto, Eva M. Serrao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3
The Role of Surgery in “Oligometastatic” Pancreas Cancer
D. Brock Hewitt, Christopher L. Wolfgang
Surgical Clinics of North America (2024) Vol. 104, Iss. 5, pp. 1065-1081
Closed Access
Interpretable multi-omics integration with UMAP embeddings and density-based clustering
Pol Castellano‐Escuder, Derek K. Zachman, Kevin Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top